Page 1

FOR IMMEDIATE RELEASE Media Contact Steve Brett , ( 224 ) 948-5353 media@baxter.com Investor Contact Clare Trachtman , ( 224 ) 948-3020 ● Baxter BAXTER REPORTS SECOND - QUARTER 2021 RESULTS Second - quarter revenue of $ 3.1 billion increased 14 % on a reported basis , 9 % on a constant currency basis and 8 % on an operational basis¹ Second - quarter U.S. GAAP earnings per share ( EPS ) of $ 0.59 increased 23 % ; Adjusted EPS of $ 0.80 increased 25 % Baxter expects full - year 2021 sales growth of approximately 8 % on a reported basis , 5 % to 6 % on a constant currency basis and 4 % to 5 % on an operational basis Baxter now expects full - year U.S. GAAP EPS of $ 2.82 to $ 2.88 and adjusted EPS of $ 3.49 to $ 3.55 DEERFIELD , III . , JULY 29 , 2021 - Baxter International Inc. ( NYSE : BAX ) , a leading global medical products company , today reported results for the second quarter of 2021 . " As markets worldwide continue to cope with the effects from the COVID - 19 pandemic , Baxter's second quarter performance reflects the diversity and durability of our lifesaving portfolio combined with the breadth of our geographic reach , " said José ( Joe ) E. Almeida , chairman , president and chief executive officer . " Our drive to innovate , the essential nature of our product lines and the momentum of our transformation are all critical factors in our effort to improve performance and extend our impact . I am looking forward to our upcoming Investor Conference in September , where we will showcase our strategies to help drive incremental value for patients , clinicians , investors and the many other stakeholders we serve . " 1 See tables to the press release for reconciliations of non - GAAP measures used in this press release to the corresponding U.S. GAAP measures .